Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice

Journal of Physiology and Pharmacology

Volumn 54, Issue 4, 2003, Pages 653-660

  Volke, Vallo ^a   Wegener, G ^b   Vasar, E ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anxiety; Nitric oxide; Plus maze; Sildenafil

Indexed keywords

ANXIOLYTIC AGENT; ARGININE; BETA CARBOLINE; CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE; SILDENAFIL;

ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; BRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENTIATION; ENZYME DEGRADATION; MALE; MAZE TEST; MOUSE; NONHUMAN; TASK PERFORMANCE;

ANIMALS; ANXIETY; ARGININE; BEHAVIOR, ANIMAL; CARBOLINES; CYCLIC GMP; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; INJECTIONS, INTRAPERITONEAL; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; NITRIC OXIDE; PIPERAZINES; TIME FACTORS;

EID: 0346733116     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Volke V, Soosaar A, Koks S, Bourin M, Mannisto PT, Vasar E. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berl) 1997; 131: 399-405.
2. Vale AL, Green S, Montgomery AM, Shafi S. The nitric oxide synthesis inhibitor L-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test. J Psychopharmacol 1998; 12: 268-272.
3. Dunn RW, Reed TA, Copeland PD, Frye CA. The nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration. Neuropharmacology 1998; 37: 899-904.
4. Monzon ME, Varas MM, De B. Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides 2001; 22: 1043-1047.
5. Salter M, Duffy C, Garthwaite J, Strijbos PJ. Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J Neurochem 1996; 66: 1683-1690.
6. De Oliveira CL, Del Bel EA, Guimaraes FS. Behavioral and c-fos expression changes induced by nitric oxide donors microinjected into the dorsal periaqueductal gray. Brain Res Bull 2000; 51: 457-464.
7. Li S, Quock RM. Effects of a nitric oxide donor on behavior and interaction with nitrous oxide in the mouse light/dark exploration test. Eur J Pharmacol 2002; 447: 75-78.
8. Eroglu L, Caglayan B. Anxiolytic and antidepressant properties of methylene blue in animal models. Pharmacol Res 1997; 36: 381-385.
9. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993; 45: 367-374.
10. Volke V, Wegener G, Vasar E, Rosenberg R. Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo. Brain Res 1999; 826: 303-305.
11. Milman HA, Arnold SB. Neurologic, psychological, and aggressive disturbances with sildenafil. Ann Pharmacother 2002; 36: 1129-1134.
12. Giordano D, De Stefano ME, Citro G, Modica A, Giorgi M. Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain. Biochim Biophys Acta 2001; 1539: 16-27.
13. Kraus MM, Prast H. Involvement of nitric oxide, cyclic GMP and phosphodiesterase 5 in excitatory amino acid and GABA release in the nucleus accumbens evoked by activation of the hippocampal fimbria. Neuroscience 2002; 112: 331-343.
14. Prickaerts J, van S, Sik A, Markerink v, Niewohner U, van d, Blokland A, de V. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 2002; 113: 351-361.
15. Baratti CM, Boccia MM. Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav Pharmacol 1999; 10: 731-737.
16. File SE. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 2001; 125: 151-157.
17. Rago L, Kiivet RA, Harro J, Pold M. Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex. Naunyn Schmiedebergs Arch Pharmacol 1988; 337: 675-678.
18. Mochida H, Inoue H, Takagi M, Noto T, Yano K, Kikkawa K, Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta. Eur J Pharmacol 2002; 440: 45-52.
19. Faria MS, Muscara MN, Moreno JH, Teixeira SA, Dias HB, De Oliveira B, Graeff FG, De Nucci G. Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test. Eur J Pharmacol 1997; 323: 37-43.
20. Volke V, Soosaar A, Koks S, Vasar E, Mannisto PT. L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats. Eur J Pharmacol 1998; 351: 287-290.
21. Yildiz F, Ulak G, Erden BF, Gacar N. Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test. Pharmacol Biochem Behav 2000; 65: 199-202.
22. Volke V, Wegener G, Bourin M, Vasar E. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behavioural Brain Research 2003; 140: 141-147.
23. Gilad R, Lampl Y, Eshel Y, Sadeh M. Drug points: Tonic-clonic seizures in patients taking sildenafil. BMJ 2002; 325: 869.